1)  Irbesartan
2-丁基-3-[邻-1H-5-四唑基苯基]苄基]-1,3-二氮杂螺[4,4]壬-1-烯-4-酮
2)  2-buty1-3-[p-(0-1H-tetrazol-5-y1-pheny1)benzy1]1,3-diazospiro[4,4]non-1-en-4-ketone
2-丁基-3-[邻-1H-5-四唑基苯基]苄基]-1,3-二氮杂螺[4,4]壬-1-烯-4-酮
3)  NO·_2
NO·2
4)  "2+2"
“2+2”
1.
Analysis of the Current Situation of "2+2" Training Way and Research on Managing Model;
2-丁基-3-[邻-1H-5-四唑基苯基]苄基]-1,3-二氮杂螺[4,4]壬-1-烯-4-酮
5)  "2×2×2"
“2×2×2”
6)  2+2+2
“2+2+2”
1.
An important background of our present banking reform is that we are undergoing banking market entry, which has the characteristics of "2+2+2".
2-丁基-3-[邻-1H-5-四唑基苯基]苄基]-1,3-二氮杂螺[4,4]壬-1-烯-4-酮
参考词条
补充资料：2-丁基-3-[邻-1H-5-四唑基苯基]苄基]-1,3-二氮杂螺[4,4]壬-1-烯-4-酮
分子式：C25H28N6O
分子量：暂无
CAS号：138402-11-6

性质：暂无

制备方法：暂无

用途：抗高血压药。

说明：补充资料仅用于学习参考，请勿用于其它任何用途。